Microarray technologies for analysis of genetic determinants of Neisseria gonorrhoeae antimicrobial resistance

Authors:

Abstract
Background. Neisseria gonorrhoeae exhibits a remarkable capacity for rapid antimicrobial resistance development. Globally, the prevalence of antimicrobial-resistant N. gonorrhoeae isolates continues to rise steadily, raising concerns about the potential emergence of untreatable infections. Aims. This work updates the distribution patterns of genetic resistance determinants in contemporary Russian clinical N. gonorrhoeae isolates to key antimicrobial agents, utilizing hydrogel microarray technology. Methods. The study included 360 N. gonorrhoeae isolates collected at the Federal State Research Center of Dermatovenereology and Cosmetology between 2019 and 2023. The susceptibility of N. gonorrhoeae to penicillin, ceftriaxone, tetracycline, azithromycin, and ciprofloxacin was determined through serial dilution in agar, with the minimum inhibitory concentration (MIC) subsequently calculated. Genetic determinants of antimicrobial resistance in N. gonorrhoeae were identified using hydrogel microarray technology. Results. The current data on the distribution of genetic determinants associated with antimicrobial resistance in N. gonorrhoeae are presented in this study. In the Russian population of gonococcus dynamic shifts are underway, leading to a redistribution of the proportion of isolates resistant or susceptible to various antimicrobial agents. Since 2020, a marked increase has been observed in the proportion of N. gonorrhoeae isolates resistant to azithromycin and ciprofloxacin. Concurrently, susceptibility to penicillin has rebounded, while the entire gonococcal population remains fully susceptible to ceftriaxone. The validated microarray-based NG-TEST diagnostic kit enables rapid detection of ceftriaxone resistance in N. gonorrhoeae by simultaneously identifying resistance-associated genetic markers in the penA, ponA, and porB genes, combined with MIC calculation. Conclusion. Microarray technologies for detecting antimicrobial resistance genetic determinants in N. gonorrhoeae serve as a complementary tool for identifying resistant strains. Microarray-based analysis informs tailored treatment strategies for patients and enables population-level surveillance of antimicrobial resistance trends in N. gonorrhoeae.

This publication has 19 references indexed in Scilit: